MET and thyroid gland undifferentiated (anaplastic) carcinoma: Human anaplastic thyroid cancer cells (KAT-18) express MET; the peptide blocked cell replication, naltrexone promoted cell growth, and anti-MET antibodies counteracted the inhibitory action mediated by MET [289].